Correlation Between CureVac NV and Iovance Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both CureVac NV and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CureVac NV and Iovance Biotherapeutics, you can compare the effects of market volatilities on CureVac NV and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Iovance Biotherapeutics.

Diversification Opportunities for CureVac NV and Iovance Biotherapeutics

-0.65

Correlation Coefficient

CureVac NV  Iovance Biotherapeutics

Excellent diversification

The 3 months correlation between CureVac and Iovance is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of CureVac NV i.e., CureVac NV and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between CureVac NV and Iovance Biotherapeutics

Given the investment horizon of 90 days CureVac NV is expected to generate 1.14 times more return on investment than Iovance Biotherapeutics. However, CureVac NV is 1.14 times more volatile than Iovance Biotherapeutics. It trades about 0.15 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.2 per unit of risk. If you would invest  275.00  in CureVac NV on October 25, 2024 and sell it today you would earn a total of  121.00  from holding CureVac NV or generate 44.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CureVac NV  vs.  Iovance Biotherapeutics

CureVac NV

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, CureVac NV exhibited solid returns over the last few months and may actually be approaching a breakup point.

Iovance Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with CureVac NV and Iovance Biotherapeutics

The main advantage of trading using opposite CureVac NV and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.

The idea behind CureVac NV and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.